Draw/line
Education and research purposes only, not medical advice. Unapproved compounds are not for human consumption. Check every result with your prescriber. Disclaimer Research and education only. Not medical advice. Disclaimer
Home / Compounds / Insulin lispro

Insulin lispro

Insulin lispro (Humalog, Admelog, Lyumjev): FDA approval history, label warnings on low blood sugar and pen sharing, and its WADA status.

FDA-approved, prescription only · Evidence grade A · Reviewed

Get an email when FDA, HHS or anti-doping status changes for Insulin lispro. Free account.
Approved and studied uses
  • FDA-approvedDiabetesHumalog, Admelog, Lyumjev
Training and drug testingBanned at all times

WADA prohibits insulins at all times under S4 (hormone and metabolic modulators).

Drug-tested athletes can look up any substance on Global DRO, run by national anti-doping agencies. Supplements can contain banned substances that are not on the label. Drawline does not suggest when to train or inject.

Insulin lispro (Humalog, Admelog, Lyumjev, rapid-acting insulin). Rapid-acting insulin analog.

AFDA-approved, prescription only. Evidence grade A: approved, large human trials.

What is Insulin lispro?

Insulin lispro is a lab-made, rapid-acting form of insulin taken around meals to control the rise in blood sugar after eating. It is injected under the skin or used in insulin pumps.

Is Insulin lispro FDA-approved?

FDA first approved Humalog in 1996 to improve blood sugar control in diabetes. Admelog, a follow-on to Humalog, was approved in December 2017, and Lyumjev (insulin lispro-aabc), a faster-acting version, was approved on June 15, 2020. Insulins became licensed biologics on March 23, 2020. It is not a controlled substance.

What does the evidence show for Insulin lispro?

Randomized trials and long clinical use in type 1 and type 2 diabetes support its approved use. There is no good evidence for use by people without diabetes.

What are the known risks of Insulin lispro?

Low blood sugar is the most common and most dangerous side effect and can be fatal; the 2025 Humalog label also warns about mix-ups between insulin products. Labels warn never to share a pen, cartridge or syringe between people, even with a new needle. Insulin can cause low potassium, which can be life-threatening. WADA prohibits insulins at all times under S4 (hormone and metabolic modulators).

How is Insulin lispro measured?

Lantus and Humalog are U-100 insulins: on a U-100 insulin syringe, each unit mark is one unit of insulin, so there is nothing to convert. Pens are pre-measured. Insulin doses come only from the prescriber.

Sources: FDA label: Humalog (insulin lispro), 2025; Lilly Medical: When did Lyumjev receive its US marketing approval?; FDA: Deemed to be a License provision of the BPCI Act; German Sport University Cologne: S4 hormone and metabolic modulators. This profile does not recommend any dose or use.

For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.

Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.